Market Cap : 132.87 B | Enterprise Value : 162.21 B | PE Ratio : 21.05 | PB Ratio : 54.93 |
---|
NAS:AMGN has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:AMGN has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Amgen's enterprise value is $162,210 Mil. Amgen's EBITDA for the trailing twelve months (TTM) ended in Jun. 2022 was $12,117 Mil. Therefore, Amgen's EV-to-EBITDA for today is 13.39.
The historical rank and industry rank for Amgen's EV-to-EBITDA or its related term are showing as below:
During the past 13 years, the highest EV-to-EBITDA of Amgen was 15.77. The lowest was 8.02. And the median was 10.89.
AMGN's EV-to-EBITDA is ranked worse thanEV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2022-08-13), Amgen's stock price is $248.39. Amgen's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2022 was $11.800. Therefore, Amgen's PE Ratio for today is 21.05.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
The historical data trend for Amgen's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - General subindustry, Amgen's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Drug Manufacturers industry and Healthcare sector, Amgen's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Amgen's EV-to-EBITDA falls into.
Amgen's EV-to-EBITDA for today is calculated as:
EV-to-EBITDA | = | Enterprise Value (Today) | / | EBITDA (TTM) |
= | 162210.474 | / | 12117 | |
= | 13.39 |
Amgen's current Enterprise Value is $162,210 Mil.
Amgen's EBITDA for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $12,117 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Amgen's PE Ratio for today is calculated as:
PE Ratio | = | Share Price (Today) | / | Earnings per Share (Diluted) (TTM) |
= | 248.39 | / | 11.800 | |
= | 21.05 |
Amgen's share price for today is $248.39.
Amgen's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $11.800.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Please read Which price ratio outperforms the enterprise multiple?
Thank you for viewing the detailed overview of Amgen's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Miller Derek | officer: SVP, Human Resources | ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 |
Khosla Rachna | officer: SVP, Business Development | ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 |
Ishrak Omar | director | 710 MEDTRONIC PKWY MS LC300 MINNEAPOLIS MN 55432 |
Louie Linda H. | officer: VP, Finance & CAO | ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 |
Miles Amy E | director | |
Grygiel Nancy A. | officer: SVP & CCO | ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 |
Griffith Peter H. | officer: EVP & CFO | ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 |
Gordon Murdo | officer: EVP Global Commercial Ops | C/O BRISTOL-MYERS SQUIBB COMPANY 345 PARK AVE NEW YORK NY 10154 |
Reese David M | officer: EVP, Research and Development | ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 |
Druker Brian | director | ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799 |
Austin Wanda M | director | 6001 BOLLINGER CANYON ROAD SAN RAMON CA 94583 |
Holley Charles M | director | |
Johnston Lori A | officer: SVP, HR | C/O AMGEN INC. ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 |
Kullman Ellen Jamison | director | UNITED TECHNOLOGIES CORP 10 FARM SPRINGS ROAD FARMINGTON CT 06032 |
Santos Esteban | officer: EVP, Operations | ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 |
Other Sources
By Fool 2022-03-16
By Seekingalpha 2022-03-08
By Zacks 2022-03-11
By tipranks.com 2022-03-22
By Zacks 2022-04-04
By Zacks 2022-03-11
By Zacks 2022-03-09
By Zacks 2022-03-22
By Zacks 2022-03-24
By tipranks.com 2022-02-23
By Zacks 2022-03-08
By Zacks 2022-03-15
By Zacks 2022-03-07
By Zacks 2022-03-16
By tipranks.com 2022-03-03